Eugene Wong, MD
Nephrology · Honolulu, HINPI 1972598605
Payments from drug & device makers
Across 538 payments — averaging $69.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$16K
- Amgen$4K
- Amarin Pharma, Inc.$3K
- Calliditas Therapeutics US Inc.$3K
- Novo Nordisk$2K
- Bayer$2K
- plus $8K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 77 | $15,904 |
| Amgen(2 entities) | 89 | $4,372 |
| Amarin Pharma, Inc. | 85 | $2,719 |
| Calliditas Therapeutics US Inc. | 15 | $2,622 |
| Novo Nordisk | 41 | $2,356 |
| Bayer | 38 | $1,930 |
| GSK | 31 | $1,497 |
| Novartis | 51 | $1,022 |
| Vifor Pharma, Inc. | 13 | $652 |
| Nxstage Medical, Inc. | 7 | $579 |
| Travere Therapeutics, Inc. | 9 | $517 |
| Ardelyx, Inc. | 9 | $492 |
| Mallinckrodt Enterprises LLC | 8 | $439 |
| Aurinia Pharma U.S., Inc. | 5 | $406 |
| Mallinckrodt Hospital Products Inc. | 6 | $307 |
| Boehringer Ingelheim | 3 | $274 |
| Akebia Therapeutics Inc | 20 | $193 |
| Baxter Healthcare | 2 | $164 |
| Amicus Therapeutics, Inc. | 6 | $149 |
| Outset Medical Inc | 1 | $140 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Sanofi | 1 | $125 |
| Vantive US Healthcare LLC | 1 | $115 |
| Veloxis Pharmaceuticals, Inc. | 1 | $111 |
| Fresenius USA Marketing, Inc. | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Kyowa Kirin, Inc. | 1 | $33 |
| AbbVie | 2 | $32 |
| Cormedix Inc. | 1 | $23 |
| Abbott | 1 | $19 |
How this compares
$37,477 in reported general payments places this provider in the 90th percentile of 57 nephrology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Honolulu
- Kunal ParekhHonolulu$172K
- Christie IzutsuHonolulu$50K
- Jared SugiharaHonolulu$39K
- Shiuh ChengHonolulu$21K
- Leilani Ka'aneheHonolulu$10K
- Antonette Veronica HernandezHonolulu$9K
- Rick HayashiHonolulu$5K
- David NaaiHonolulu$5K
- Arie Olivo GanzHonolulu$5K
- Sorkko ThirunavukkarasuHonolulu$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.